丙型肝炎（丙肝）者50％以上发展成慢性肝炎，其肝组织清理改变可日益加重。近年，国内外用干扰素治疗丙肝取得初步疗效［1～3］。本院于1992年起用重组α-2b干扰素（α－2b－IFN）联合病毒叹治疗丙肝19例，并与单用α－2b－IFN相对照，旨在提高治愈好转率，经随访已2年余，报 More than 50% of hepatitis C (hepatitis C) develop chronic hepatitis, liver tissue changes may be increasing. In recent years, at home and abroad with interferon treatment of hepatitis C achieved initial effect [1 ~ 3]. The hospital in 1992 with recombinant interferon α-2b (α-2b-IFN) combined with viral sigh treatment of hepatitis C 19 cases, and with single α-2b-IFN in comparison, aimed at improving the cure rate, have been followed up 2 More than a year, reported